Single- And Multiple-Dose Pharmacokinetics and Safety of Pimodivir, a Novel, Non-Nucleoside Polymerase Basic Protein 2 Subunit Inhibitor of the Influenza a Virus Polymerase Complex, and Interaction With Oseltamivir: A Phase 1 Open-Label Study in Healthy V
British Journal of Clinical Pharmacology - United Kingdom
doi 10.1111/bcp.13733
Full Text
Open PDFAbstract
Available in full text
Categories
Date
September 14, 2018
Authors
Publisher
Wiley